New arrangements for MHRA Good Practice (GxP) inspections due to coronavirus (COVID-19)
As part of our response to the coronavirus outbreak, we have decided to conduct only essential Good Practice (GxP) inspections of Laboratories, Clinical Trials, Manufacturing, Distribution and Pharmacovigilance until further notice. Other MHRA inspect… read more